🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral semaglutide 50mg (Rybelsus HD) — 12 month update Page 2

Oral semaglutide 50mg (Rybelsus HD) — 12 month update

LibrarianMeg Mon, Mar 4, 2024 at 6:09 AM 44 replies 2,300 viewsPage 2 of 9
pam_columbus
Member
312
1,345
Aug 2024
Columbus, OH
Mar 4, 2024 at 8:59 AM#6

Wait there's going to be a 50mg oral version?? That would be a game changer honestly. I would switch in a heartbeat if the efficacy matched injectable.

33 10kevin_tulsa, Dr.PainCLE, mike_mealprep and 30 others
Reply Quote Save Share Report
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Mar 4, 2024 at 9:16 AM#7

For the travel issue specifically — a few tips that helped me keep using injectable while traveling constantly:

  • FRIO insulin cooling wallets — no refrigeration needed, just soak in water. Keeps pens cool for 48-72 hours.
  • TSA has NEVER given me an actual problem with my Wegovy pens. I keep them in a clear bag with the prescription label visible. Just tell them it's medication.
  • Most hotels will put medication in their kitchen fridge if you ask the front desk.
  • Wegovy pens are actually stable at room temperature (up to 86°F/30°C) for up to 28 days, so for short trips you might not even need refrigeration.
22 3MounjBrad, nick_newbie, DadBodDave and 19 others
Reply Quote Save Share Report
mike_nyc
VIP Member
5,678
21,345
Nov 2023
New York
Online
Mar 4, 2024 at 9:33 AM#8

Ok this is all super helpful. It sounds like switching to oral at my current dose (1.7mg injectable) would be a downgrade in efficacy, and the daily fasting requirement might actually be MORE of a hassle than weekly injections.

I think I'll stick with injectable and try the FRIO wallet for travel. And keep my eye out for when/if the higher-dose oral formulation gets approved.

Thanks everyone — saved me from making a mistake! 🙏

6 24Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 3 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Mar 4, 2024 at 9:50 AM#9

Smart decision. One more data point: the oral 50mg formulation from OASIS 1 also had higher rates of GI side effects compared to injectable 2.4mg in cross-trial comparisons. The 50mg pill delivers a LOT of semaglutide to the stomach lining even if only 1% is absorbed systemically, and that local GI exposure may cause more nausea/vomiting. Something to factor in if/when it becomes available.

— pharma_data_guy | PharmD | GLP-1 pharmacology nerd
Last edited: Mar 4, 2024 at 10:50 AM
47 18VendorMark, COA_Karl, MikeFit_NJ and 44 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register